Filter
1180
Filtered Results: 1180
Text search:
rifampicin
Featured
Recommendations
131
New Publications
309
Language
Document type
No document type
777
Guidelines
169
Studies & Reports
97
Manuals
58
Strategic & Response Plan
27
Training Material
20
Fact sheets
20
Situation Updates
7
Infographics
3
App
1
Resource Platforms
1
Countries / Regions
India
62
Western and Central Europe
60
Eastern Europe
36
Nepal
27
South Africa
27
Kenya
22
Latin America and the Carribbean
22
Argentina
19
Tanzania
18
Colombia
16
Nigeria
15
Peru
15
Global
14
Germany
14
Paraguay
14
Bangladesh
14
Uganda
14
Namibia
14
Ethiopia
14
Zambia
13
Indonesia
13
Rwanda
12
Malawi
12
Brazil
12
El Salvador
11
Senegal
11
Myanmar / Burma
11
Ukraine
10
Philippines
10
Bolivia
10
Cambodia
9
South–East Asia Region
9
Cameroon
8
Mozambique
8
Asia
8
Congo, Democratic Republic of
8
Africa
7
Russia
7
Tajikistan
5
Ghana
5
Benin
5
Zimbabwe
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Chile
4
Burkina Faso
4
Venezuela
4
Botswana
4
Liberia
4
Madagascar
4
Lesotho
3
Sierra Leone
3
Haiti
3
Georgia
3
Bhutan
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Jordan
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Central African Republic
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Guinea
1
USA
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Tunisia
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
270
TB
88
Guidelines
74
Studies & Reports
57
Drugs & Medical Equipment
49
Capacity Building
33
Policies
26
Women & Child Health
23
Pediatrics
22
HIV & STI
22
Statistics
18
Disease Prevention & Control
13
Community Health
12
Paediatrics
11
Bacteriology
9
Reproductive Health
9
Buruli Ulcer
8
COVID-19
8
Leprosy
8
Dermatology
7
Leprosy
7
Family Planning
6
Maternal & Child Health
5
Countries
5
Clinical Guidelines
5
Demograhic Health Surveys DHS
5
Communicable Diseases
5
NTDs & Others
5
Community Health
4
Vaccine-preventable Diseases
4
Communicable Diseases
3
Infection Control & Prevention (IPC)
3
Public Health
3
Health Systems
3
Clinical Training
2
Hepatitis
2
Under-5 nutrition
2
Diabetes
2
Trachoma
2
Lymphaticfilariasis
2
Humanitarian Aid
2
Monitoring & Evaluation
2
Virology
2
Medical Devices & Equipment
2
Information, Education and Communication (IEC)
2
Humanitarian Crisis
2
Other
2
General Guidelines
2
Leishmaniasis
2
Dental & Eye Care
1
Public Health
1
Pharmacy & Technology
1
Child Health
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
Palliative Care
1
IEC Material
1
Health System Strengthening
1
NCD
1
Disabilities
1
Palliative Care
1
Respiratory Infections
1
Needs Assessment
1
Primary Health Care
1
Malaria
1
Pharmacy & Technologies
1
Toolboxes
Prevention & Control
57
Drug resistant TB
55
Detection & Diagnosis
52
Adults
49
Children
31
Training
26
TB/HIV Coinfection
25
Essential Medicines & Devices Lists
23
TB & Prisoners
20
Reports
19
Childhood TB
18
Antiretroviral Treatment ART
18
Policies & Strategies
15
General
15
Research & Access
15
Clinical Aspects, Treatment & Prevention
14
Children & Adolescents
14
Disease Prevention & Control
14
TB
14
Treatment & Prevention
13
Laboratory
13
Clinical Aspects & Diagnostics
13
Clinical Aspects
12
Colombia
12
Peru
12
Argentina
12
AmR (Region of Americas)
12
Eastern Europe & Central Asia
12
Brazil
11
Other Countries
11
Romania
11
Germany
11
Country specific
10
Reports & Studies
10
SEAR (South-east Asia Region)
10
Moldova
9
Policies & Strategies
9
Treatment Guidelines HIV
9
Prevention & Control
9
El Salvador
9
Essential Medicines
9
Studies & Reports
9
TB & Drug Abuse
8
TB & Other Vulnerable Populations
8
International
8
TB/HIV
8
General
8
HIV and coinfection
8
Biosafety
7
South Africa
7
Country Guidelines
7
Advocacy & Communication
7
HIV &TB
7
Policies and guidelines
7
Tuberculosis
7
Clinical Guidelines
7
Kenya
7
Treatment & Clinical Management
7
Opportunistic Infections
6
Namibia
6
Drug resistance
6
Communication & Training
6
Studies
6
Community Health Workers CHW
6
Overview
6
TB/HIV Global
6
Uganda
6
South-east Asia Region
6
Epidemiology
6
ART Drug Resistance
5
Ukraine
5
IEC Materials
5
Rwanda
5
TB/COVID-19
5
Rational use of Medicine
5
Diagnosis
5
Malawi
5
Nutrition
5
Latin America & the Carribean
5
Assessment
5
General Reports
4
Azerbaijan
4
Vaccines & Immunization
4
Training Manuals
4
TB
4
SOPs
4
Ethiopia
4
Clinical Guidelines
4
Clinical Guidelines
4
Country Specific
4
Chile
4
Ecuador
4
Falsified & Substandard
4
Co-Morbidities (except TB)
4
Prophylactic Treatment
4
Nigeria
4
Tajikistan
4
Kazakhstan
4
Western & Central Europe
4
Eastern Europe and central Asia
4
Agriculture & Veterinary
3
Epidemiology & Sitreps
3
Eastern Mediterranean Region
3
National Policies
3
Mozambique
3
Georgia
3
Clinical aspects
3
Workplace
3
Essential List
3
Country specific documents
3
Global Impact: Socio-economic, health services, TB & HIV
3
Hospital Readiness/Essential Health Services
3
Latin America
3
Others
3
Pharmacy Practice
3
Information & Education Material (IEC)
3
Capacity Building & Resource platforms
3
Access to treatment and laboratory
3
Drugs
2
Behaviour Change/Life Skill Education
2
Meningitis Prevention & Control
2
Clinical Guidelines
2
Pediatrics
2
WPRO (Western Pacific Region)
2
Prevention Guidelines
2
Policies
2
HIV
2
Prophylaxis
2
Health & Refugee
2
Laboratory
2
Epilepsy
2
Sustainable Development Goals
2
Russia
2
General
2
Latin America
2
Prices and Patents
2
Model Formulary
2
Guidelines & Manuals
2
Prevention & Measures
2
Disability Prevention & Rehabilitation
2
NTDs General
2
Health Worker
2
Neurological Disorders
2
Ghana
2
HIV service delivery
2
Lobby and Advocacy
2
Meningitis & Encephalitis
2
Clinical Guidelines
1
Assessment & Studies
1
Surveillance
1
HIV testing & services
1
Clinical Guidelines
1
Zambia
1
Social Mobilisation
1
Social Worker
1
Public Health
1
Eastern Europe
1
Global
1
People who injecting Drugs
1
Vaccination
1
African Region
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
DR Congo
1
Laboratory
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Research & Development
1
Handbooks & Manuals
1
Primary Care
1
Nurses
1
Estonia
1
Pharmacy Management
1
Pharmaceutical Assessments
1
Supply Chain & Store Management
1
General documents One Health
1
General
1
Health Care In Conflict Settings
1
Leishmaniasis
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Clinical Aspects & Diagnostics
1
Vector control
1
Armenia
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Botswana
1
General
1
Substance Use Disorders & Addiction
1
Community Worker
1
General Aspects
1
Regional Reports & Guidelines, others
1
AR (African Region)
1
Education of students & professionals
1
Lesotho
1
Stewardship
1
HIV / AIDS
1
Testing Guidelines
1
Others
1
Stigma
1
Overview & Statistics
1
MHPSS Guidelines
1
Guidelines CBR
1
Reports & Studies Children HIV
1
HIV in Key Populations
1
Preparedness & Prevention
1
Global Health Financing
1
Unaccompanied Refugee Minors
1
Case Definitions
1
Prisoners
1
Key Resources
1
AMR
1
Volunteers
1
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation...
Consenso de los Laboratorios Supranacionales (LSN), Centros Colaboradores (CC) y Laboratorios Nacionales de Referencia (LNR) de “países priorizados” para la aplicación del Xpert-MTB/Rif en Las Américas.
Guatemala, 11-12 abril de 2011
Accessed December 2017
Accessed March 19,2015
Technical and operational ‘how-to’: practical considerations
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequency of M. tuberculosis strains that were resistant...
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
La publicación describe el método aplicado en los laboratorios que han realizado la validación, como un método rápido de tamizaje para la detección de resistencia a isoniacida y rifampicina en muestras de esputo de pacientes con tuberculosis pulmonar que aún no hayan iniciado tratamiento anti...
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
Buruli ulcer is caused by infection with Mycobacterium ulcerans. The disease is reported in more than 33 countries worldwide, but only about half of these countries regularly report data to WHO; most cases are reported from subregions of West and Central Africa. The mode of transmission is not known...
L’ulcère de Buruli, une infection causée par Mycobacterium ulcerans, touche plus de 33 pays dans le monde, mais un peu moins de la moitié seulement de ces pays communiquent régulièrement des données sur la maladie à l’OMS. La plupart des cas notifiés se trouvent dans les sous-régions d...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
